Literature DB >> 23484386

Malaria--a disease of travellers.

Krzysztof Korzeniewski1, Katarzyna Pieruń.   

Abstract

The number of people travelling to regions with hot climate such as Asia, Africa and South America increases steadily every year. The reason for travel varies greatly, from business trips to tourist excursions, the latter definitely prevailing. There has been an increase in travel to destinations where exposure to vector-borne, food- and water-borne, air-borne or sexually transmitted pathogens is common. As one of vector-borne diseases, malaria poses as a serious health hazard to local as well as immigrant populations. Over 40% of the world's inhabitants live in malaria-endemic regions. Although highly developed countries of North America and Europe are generally free from endemic malaria foci, numerous cases of imported infections are observed. Some cases of malaria are also reported in Poland, they are usually brought by persons returning from tropical regions in Africa, Asia, South America, Australia and Oceania. The number of cases depends on the destination as well as on the use or rejection of chemoprophylaxis. The article provides general information on epidemiology, pathogenesis, clinical manifestation and diagnosis of malaria. Emphasis has been put on treatment as well as on chemoprophylaxis of the disease, which are changing relatively quickly, what is mainly related to increasing Plasmodium resistance to applied medicines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23484386

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  2 in total

1.  Contact infection of infectious disease onboard a cruise ship.

Authors:  Nan Zhang; Ruosong Miao; Hong Huang; Emily Y Y Chan
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

Review 2.  Plasmodium knowlesi as a Threat to Global Public Health.

Authors:  Roland Wesolowski; Alina Wozniak; Celestyna Mila-Kierzenkowska; Karolina Szewczyk-Golec
Journal:  Korean J Parasitol       Date:  2015-10-29       Impact factor: 1.341

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.